Non Thermal Irreversible Electroporation treatment, developed by Bioenginering and Mechanical Engineering professor Boris Rubinsky, is now the technology behind the Nanoknife. Licensed from Berkeley by AngioDynamics, the Nanoknife uses electric currents to quickly and easily reach remote tumors in prostate cancer. University College London Hospital was recently the first hospital to use the treatment in the British National Health Service.
